James Dondero is co-founder and President of Highland Capital Management, LP, located in Dallas, Texas. Though a busy man with many responsibilities, James Dondero is involved in many philanthropic endeavors.
In 1993, James Dondero started his own company, Highland Capital Management and has since then succeeded in developing his investment firm into one of the largest alternative credit managers in the United States as well as around the globe. The firm handles unique credit cases, credit hedge funds, and private equity accounts. Dondero finds time to be involved in charity while dedicated to his work. Visit nexpointliving.com to know more about James Dondero.
James Dondero has stayed involved with his Dallas community by being part of many charitable projects. One project involved the Dallas Zoo. In 2001 the Dallas Zoo, after an elderly Hippo died, closed the habitat for the species. In an effort to rebuild the hippopotamus habitat, James Dondero recently contributed $1 million. James Dondero’s generosity spurred the combined contributions of other philanthropist amounting to $14 million, enough to reopen the hippo habitat for visitors to enjoy today.
James Dondero’s interest lies with his company assisting in projects that will impact the future of Dallas in a positive way. Concerned about the Dallas community, James Dondero has contributed in other ways besides assisting with the rebuilding of the hippopotamus habit at the Zoo. James Dondero and Highland Capital Management also donated money to the Perot Museum of Natural Science, the George W. Bush Library and Institute, and was involved with Uplift Education and the Snowball Express.
One of James Dondero’s main goals when he started Highland Capital Management LP was to participate in charitable projects that would benefit the Dallas community. He is particularly interested in ventures that bring Dallas into a positive future. Dondero enjoys promoting educational experiences to the public, such as helping to provide a habit for hippos. James Dondero is not interested in entrepreneurship in order to become more powerful and only be concerned with himself. His desire is to use his business to be able to give back to his community, promote educational experiences, and establish a positive future for Dallas. Read more at Huffington Post about James Dondero.
Scott M. Rocklage started working for 5AM ventures as a partner in 2003 and later became the Managing Partner. He is a personality who has over 30 years of experience in healthcare management involving strategic leadership responsibilities.
He has also served as Chairman and Chief operating officer of Cubist pharmaceuticals, Nycomed Salutar. He has also worked with Salutar and Novira in Research and Development.
Currently, he serves as the Board Chairman of Kenistral Rennovia and Cidara. The other boards that he has also served include Pulmatrix and Epirus. He was formerly the Executive Chairman of Miikana, IIypsa, and Semprus. Academically, he has a B.S. in Chemistry from the University of California and a Chemistry Ph.D from MIT. He is associated with the invention and co-inventions of over 30 US patents with over one hundred peer-reviewed publications.
5AM ventures is a science based venture capital firm that is run by Rocklage on a daily basis. He works with entrepreneurs in the field of science and medicine, and helps to refine their ideas to create real medicines to treat people. His area of expertise involves the development of medicine capable of containing cancer.
He mainly focuses on particular genotypes or mutations in his quest to providing cancer treatment in a unique way. His contributions to medicine have been able to save and extend the lives of many people. He pays special attention to time management, prioritization, and calendaring. Read more: Scott Rocklage | LinkedIn and Idea Mensch | Scott Rocklage
He is known for staying true to medicine as a profession and through his various contributions in this field. He was involved with entering six drug candidates for clinical trials. FDA approved three of his applications for new drugs. 5AM ventures, which he runs, is a firm that focuses on startup companies involving the media to provide equity.
It is involved in the business of buying shares from such companies to improve their capital transactions to get advertising space. It is currently headquartered in Paris, France.
Scott is currently involved in philanthropic activities by contributing to political agendas and several companies. He was also involved in contributions towards the development and renovation of nanotechnology laboratories